According to the Complaint, MedEquities Realty Trust, Inc. is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments.

On January 2, 2019, Omega Healthcare Investors, Inc. and MedEquities issued a joint press release announcing the Proposed Transaction, pursuant to which MedEquities will be acquired by Omega.

On February 11, 2019, Omega filed a registration statement containing a joint proxy statement/prospectus on Form S-4 (“Registration Statement”) with the SEC in connection with the Proposed Transaction. The Complaint alleges that the Registration Statement, which recommends that MedEquities stockholders vote in favor of the Proposed Transaction, omits or misrepresents material information concerning, among other things: (i) the actual intrinsic standalone value of the Company and Omega; (ii) the financial analyses performed by the Company’s financial advisor; (iii) the background of the Proposed Transaction; and (iv) the Company's financial advisor's potential conflicts of interest.

On August 8, 2019, the Court issued an Order appointing Lead Plaintiff and Counsel. This case was voluntarily dismissed on October 18.